Tenax Therapeutics (TENX) Cash from Operations (2010 - 2026)
Tenax Therapeutics recorded quarterly Cash from Operations of 9300000.0 in Q1 2026, up 30.6% quarter-over-quarter from 13400000.0 in Q4 2025, and down 32.86% year-over-year from 13851063.83 in Q1 2025.
Tenax Therapeutics' Cash from Operations history runs 17 years deep, the most recent figure standing at 9300000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 32.86% year-over-year to 9300000.0; the TTM figure through Mar 2026 stood at 38100000.0 (down 129.52% YoY), while the FY2025 annual figure was 35800000.0, down 141.89% from the prior year.
- Cash from Operations came in at 9300000.0 for Q1 2026 at Tenax Therapeutics, up from 13400000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 922966.0 in Q2 2023 to a low of 13400000.0 in Q4 2025.
- A 5-year average of 4540739.47 and a median of 3330905.0 in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations surged 73.1% in 2023 and sank 281.11% in 2025, its largest moves.
- Tenax Therapeutics' Cash from Operations stood at 1688780.0 in 2022, then jumped by 30.42% to 1175008.0 in 2023, then slumped by 199.23% to 3516000.0 in 2024, then tumbled by 281.11% to 13400000.0 in 2025, then jumped by 30.6% to 9300000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 9300000.0, 13400000.0, and 9200000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | -9.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.30 Mn |
| Mar 31, 2026 | -9.30 Mn |
| Dec 31, 2025 | -13.40 Mn |
| Dec 31, 2025 | -13.40 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Mar 31, 2025 | -7.00 Mn |
| Mar 31, 2025 | -7.00 Mn |
| Dec 31, 2024 | -3.52 Mn |
| Dec 31, 2024 | -3.52 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -3.00 Mn |
| Jun 30, 2024 | -3.00 Mn |
| Mar 31, 2024 | -5.20 Mn |
| Mar 31, 2024 | -5.20 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Sep 30, 2023 | -2.08 Mn |
| Sep 30, 2023 | -2.08 Mn |
| Jun 30, 2023 | -922,966.00 |
| Jun 30, 2023 | -922,966.00 |
| Mar 31, 2023 | -1.72 Mn |
| Mar 31, 2023 | -1.72 Mn |
| Dec 31, 2022 | -1.69 Mn |
| Dec 31, 2022 | -1.69 Mn |
| Sep 30, 2022 | -3.33 Mn |
| Sep 30, 2022 | -3.33 Mn |
| Jun 30, 2022 | -3.43 Mn |
| Jun 30, 2022 | -3.43 Mn |
| Mar 31, 2022 | -2.94 Mn |
| Mar 31, 2022 | -2.94 Mn |
| Dec 31, 2021 | -2.77 Mn |
| Dec 31, 2021 | -2.77 Mn |
| Sep 30, 2021 | -3.02 Mn |
| Sep 30, 2021 | -3.02 Mn |
| Jun 30, 2021 | -1.85 Mn |
| Jun 30, 2021 | -1.85 Mn |
| Mar 31, 2021 | -3.22 Mn |
| Mar 31, 2021 | -3.22 Mn |
| Dec 31, 2020 | -1.99 Mn |
| Dec 31, 2020 | -1.99 Mn |
| Sep 30, 2020 | -2.39 Mn |
| Sep 30, 2020 | -2.39 Mn |
| Jun 30, 2020 | -2.23 Mn |
| Jun 30, 2020 | -2.23 Mn |
| Mar 31, 2020 | -2.67 Mn |
| Mar 31, 2020 | -2.67 Mn |
| Dec 31, 2019 | -1.73 Mn |
| Dec 31, 2019 | -1.73 Mn |
| Sep 30, 2019 | -1.78 Mn |
| Sep 30, 2019 | -1.78 Mn |
| Jun 30, 2019 | -1.91 Mn |
| Jun 30, 2019 | -1.91 Mn |
| Mar 31, 2019 | -2.13 Mn |
| Mar 31, 2019 | -2.13 Mn |
| Dec 31, 2018 | -1.20 Mn |
| Dec 31, 2018 | -1.20 Mn |
| Sep 30, 2018 | -1.56 Mn |
| Sep 30, 2018 | -1.56 Mn |
| Jun 30, 2018 | -1.19 Mn |
| Jun 30, 2018 | -1.19 Mn |
| Mar 31, 2018 | -1.56 Mn |
| Mar 31, 2018 | -1.56 Mn |
| Dec 31, 2017 | -1.28 Mn |
| Dec 31, 2017 | -1.28 Mn |
| Sep 30, 2017 | -1.23 Mn |
| Sep 30, 2017 | -1.23 Mn |
| Jun 30, 2017 | -5.60 Mn |
| Jun 30, 2017 | -5.60 Mn |
| Mar 31, 2017 | -4.04 Mn |
| Mar 31, 2017 | -4.04 Mn |
| Dec 31, 2016 | -3.11 Mn |
| Dec 31, 2016 | -3.11 Mn |
| Sep 30, 2016 | -4.28 Mn |
| Sep 30, 2016 | -4.28 Mn |
| Jun 30, 2016 | -5.17 Mn |
| Jun 30, 2016 | -5.17 Mn |
| Mar 31, 2016 | -3.32 Mn |
| Mar 31, 2016 | -3.32 Mn |
| Dec 31, 2015 | -8.95 Mn |
| Dec 31, 2015 | -8.95 Mn |
| Sep 30, 2015 | -3.13 Mn |
| Sep 30, 2015 | -3.13 Mn |
| Jun 30, 2015 | -3.36 Mn |
| Jun 30, 2015 | -3.36 Mn |
| Jul 31, 2014 | -1.98 Mn |
| Jul 31, 2014 | -1.98 Mn |
| Apr 30, 2014 | -2.98 Mn |
| Apr 30, 2014 | -2.98 Mn |
| Jan 31, 2014 | -2.71 Mn |
| Jan 31, 2014 | -2.71 Mn |
| Oct 31, 2013 | -2.01 Mn |
| Oct 31, 2013 | -2.01 Mn |
| Jul 31, 2013 | -1.56 Mn |
| Jul 31, 2013 | -1.56 Mn |
| Apr 30, 2013 | -1.44 Mn |
| Apr 30, 2013 | -1.44 Mn |
| Jan 31, 2013 | -739,010.00 |
| Jan 31, 2013 | -739,010.00 |
| Oct 31, 2012 | -1.13 Mn |
| Oct 31, 2012 | -1.13 Mn |
| Jul 31, 2012 | -1.61 Mn |
| Jul 31, 2012 | -1.61 Mn |
| Apr 30, 2012 | -1.42 Mn |
| Apr 30, 2012 | -1.42 Mn |
| Jan 31, 2012 | -2.27 Mn |
| Jan 31, 2012 | -2.27 Mn |
| Oct 31, 2011 | -2.53 Mn |
| Oct 31, 2011 | -2.53 Mn |
| Jul 31, 2011 | -2.05 Mn |
| Jul 31, 2011 | -2.05 Mn |
| Apr 30, 2011 | -1.75 Mn |
| Apr 30, 2011 | -1.75 Mn |
| Jan 31, 2011 | -2.26 Mn |
| Jan 31, 2011 | -2.26 Mn |
| Oct 31, 2010 | -1.78 Mn |
| Oct 31, 2010 | -1.78 Mn |
| Jul 31, 2010 | -2.61 Mn |
| Jul 31, 2010 | -2.61 Mn |